FOXP1 and Cowden syndrome 1: Being a small recombinant protein with proven efficacy in other diseases (11–15, 20), mfH offers a new strategy against CS in combination with other drugs and treatment modalities, obviously after intense preclinical analysis of efficacy and safety.